Pulse Biosciences (PLSE) News Today $16.73 +0.79 (+4.96%) Closing price 04:00 PM EasternExtended Trading$16.25 -0.48 (-2.88%) As of 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Pulse Biosciences (NASDAQ:PLSE) Upgraded by StockNews.com to Sell RatingStockNews.com upgraded Pulse Biosciences to a "sell" rating in a research note on Monday.April 1 at 11:17 PM | marketbeat.comEarnings call transcript: Pulse Biosciences Q4 2024 misses EPS, stock risesMarch 29, 2025 | investing.comPulse Biosciences (NASDAQ:PLSE) Shares Gap Up - Here's WhyPulse Biosciences (NASDAQ:PLSE) Shares Gap Up - Here's What HappenedMarch 29, 2025 | marketbeat.comPulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2024 Earnings Call TranscriptMarch 29, 2025 | insidermonkey.comComparing Beyond Air (NASDAQ:XAIR) & Pulse Biosciences (NASDAQ:PLSE)March 29, 2025 | americanbankingnews.comPulse Biosciences (NASDAQ:PLSE) Issues Quarterly Earnings ResultsPulse Biosciences (NASDAQ:PLSE - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.27) EPS for the quarter.March 28, 2025 | marketbeat.comPulse Biosciences reports wider Q4 loss, shares dipMarch 27, 2025 | investing.comPulse Biosciences, Inc. (PLSE) Q4 2024 Earnings Call TranscriptMarch 27, 2025 | seekingalpha.comPulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial ResultsMarch 27, 2025 | businesswire.comPulse Biosciences To Present at the 24th Annual Needham Virtual Health Care ConferenceMarch 26, 2025 | businesswire.comPulse Biosciences (NASDAQ:PLSE) Trading Down 2.9% - Here's WhyPulse Biosciences (NASDAQ:PLSE) Trading Down 2.9% - Time to Sell?March 15, 2025 | marketbeat.comOppenheimer & Co. Inc. Acquires New Shares in Pulse Biosciences, Inc. (NASDAQ:PLSE)Oppenheimer & Co. Inc. acquired a new stake in shares of Pulse Biosciences, Inc. (NASDAQ:PLSE - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund acquired 17,850 shares of the company's stock, valued at approximately $311,000. A number of other hedgeMarch 9, 2025 | marketbeat.comPulse Biosciences at TD Cowen Conference: nsPFA Technology FocusMarch 8, 2025 | investing.comPulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025March 7, 2025 | businesswire.comCommit To Purchase Pulse Biosciences At $10, Earn 12.9% Annualized Using OptionsMarch 6, 2025 | nasdaq.comPulse Biosciences (NASDAQ:PLSE) Share Price Crosses Below 50 Day Moving Average - Time to Sell?Pulse Biosciences (NASDAQ:PLSE) Share Price Crosses Below 50-Day Moving Average - What's Next?March 4, 2025 | marketbeat.comPulse Biosciences Inc (6L8.SG)March 1, 2025 | au.finance.yahoo.comPulse Biosciences (NASDAQ:PLSE) Shares Down 7.8% - Here's WhyPulse Biosciences (NASDAQ:PLSE) Trading Down 7.8% - Time to Sell?February 20, 2025 | marketbeat.comPulse Biosciences To Present at the TD Cowen 45th Annual Health Care ConferenceFebruary 20, 2025 | businesswire.comPLSE Stock Earnings: Pulse Biosciences Reported Results for Q2 2024February 14, 2025 | investorplace.comPulse Biosciences (NASDAQ:PLSE) Stock Price Down 6.6% - Here's What HappenedPulse Biosciences (NASDAQ:PLSE) Trading Down 6.6% - Here's WhyFebruary 6, 2025 | marketbeat.comPulse Biosciences (NASDAQ:PLSE) Reaches New 1-Year High - Time to Buy?Pulse Biosciences (NASDAQ:PLSE) Hits New 12-Month High - Should You Buy?February 4, 2025 | marketbeat.comPulse Biosciences names Jon Skinner as new CFOFebruary 4, 2025 | msn.comPulse Biosciences names Jon Skinner as CFO, effective Feb 3February 4, 2025 | markets.businessinsider.comPulse Biosciences Appoints Jon Skinner As CFO; Stock Up In Pre-marketFebruary 4, 2025 | markets.businessinsider.comPulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial OfficerFebruary 4, 2025 | finance.yahoo.comPulse Biosciences (NASDAQ:PLSE) Trading Up 7.6% - Still a Buy?Pulse Biosciences (NASDAQ:PLSE) Trading 7.6% Higher - Still a Buy?January 31, 2025 | marketbeat.comGriffin Asset Management Inc. Has $4.14 Million Holdings in Pulse Biosciences, Inc. (NASDAQ:PLSE)Griffin Asset Management Inc. lessened its stake in Pulse Biosciences, Inc. (NASDAQ:PLSE - Free Report) by 7.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 237,547 shares of the company's stock after selling 19,902 shJanuary 28, 2025 | marketbeat.comPulse Biosciences (NASDAQ:PLSE) Trading Up 5.2% - What's Next?Pulse Biosciences (NASDAQ:PLSE) Shares Up 5.2% - What's Next?January 21, 2025 | marketbeat.comPulse Biosciences reports successful AF treatment in studyJanuary 21, 2025 | msn.comBarclays PLC Grows Position in Pulse Biosciences, Inc. (NASDAQ:PLSE)Barclays PLC lifted its position in shares of Pulse Biosciences, Inc. (NASDAQ:PLSE - Free Report) by 361.4% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 30,306 shares of the company's stock after purJanuary 18, 2025 | marketbeat.comPulse Biosciences announces Paul LaViolette as CEOJanuary 10, 2025 | markets.businessinsider.comPulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive OfficerJanuary 10, 2025 | gurufocus.comPulse Biosciences Appoints Co-Chairman Paul LaViolette As CEOJanuary 10, 2025 | markets.businessinsider.comPulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive OfficerJanuary 10, 2025 | finance.yahoo.comPulse Biosciences To Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 3, 2025 | finance.yahoo.comPulse Biosciences (NASDAQ:PLSE) Trading 6.1% Higher - Should You Buy?Pulse Biosciences (NASDAQ:PLSE) Shares Up 6.1% - Here's What HappenedJanuary 3, 2025 | marketbeat.comGeode Capital Management LLC Grows Position in Pulse Biosciences, Inc. (NASDAQ:PLSE)Geode Capital Management LLC boosted its position in shares of Pulse Biosciences, Inc. (NASDAQ:PLSE - Free Report) by 7.8% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 457,165 shares of the company's stock after purchasiJanuary 3, 2025 | marketbeat.comPulse Biosciences (NASDAQ:PLSE) Rating Increased to Sell at StockNews.comStockNews.com raised Pulse Biosciences to a "sell" rating in a report on Thursday.January 2, 2025 | marketbeat.comState Street Corp Buys 69,696 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE)State Street Corp grew its holdings in shares of Pulse Biosciences, Inc. (NASDAQ:PLSE - Free Report) by 17.8% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 461,333 shares of the company's stock after purchasing an additioDecember 28, 2024 | marketbeat.comPulse Biosciences (NASDAQ:PLSE) Trading Down 2.2% - Time to Sell?Pulse Biosciences (NASDAQ:PLSE) Stock Price Down 2.2% - Time to Sell?December 26, 2024 | marketbeat.comPulse Biosciences: Constructive On Nano-Pulse AssetsDecember 25, 2024 | seekingalpha.comPulse Biosciences (NASDAQ:PLSE) Shares Gap Up - Should You Buy?Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up - Still a Buy?December 24, 2024 | marketbeat.comPulse Biosciences (NASDAQ:PLSE) Stock Rating Upgraded by StockNews.comStockNews.com upgraded Pulse Biosciences to a "sell" rating in a report on Tuesday.December 24, 2024 | marketbeat.comPulse Biosciences, Inc. Announces Planned Redemption of WarrantsDecember 23, 2024 | businesswire.comPulse Biosciences, Inc. (NASDAQ:PLSE) CEO Sells $871,000.00 in StockDecember 21, 2024 | insidertrades.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Makes New $588,000 Investment in Pulse Biosciences, Inc. (NASDAQ:PLSE)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in Pulse Biosciences, Inc. (NASDAQ:PLSE - Free Report) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 33,535 shares of the compaDecember 21, 2024 | marketbeat.comPulse Biosciences Inc.December 20, 2024 | wsj.comInsider Selling: Pulse Biosciences, Inc. (NASDAQ:PLSE) CEO Sells 50,000 Shares of StockPulse Biosciences, Inc. (NASDAQ:PLSE - Get Free Report) CEO Burke Thomas Barrett sold 50,000 shares of the stock in a transaction that occurred on Wednesday, December 11th. The stock was sold at an average price of $17.42, for a total value of $871,000.00. Following the completion of the transaction, the chief executive officer now owns 63,172 shares in the company, valued at approximately $1,100,456.24. The trade was a 44.18 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link.December 20, 2024 | marketbeat.comPulse Biosciences, Inc. Announces Election to Exercise Company WarrantsDecember 19, 2024 | businesswire.com Remove Ads Get Pulse Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PLSE and its competitors with MarketBeat's FREE daily newsletter. Email Address PLSE Media Mentions By Week PLSE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PLSE News Sentiment▼0.080.57▲Average Medical News Sentiment PLSE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PLSE Articles This Week▼103▲PLSE Articles Average Week Remove Ads Get Pulse Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PLSE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies IRTC News Today SLNO News Today PRCT News Today NVST News Today TMDX News Today ENOV News Today LIVN News Today NVCR News Today LMAT News Today WRBY News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PLSE) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulse Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulse Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PLSE Stock Free PLSE Stock Alerts